ION BLUE RESEARCH DIRECTORY
Antimicrobial Peptides
Short, often naturally occurring host-defense peptides studied for interactions with microbial membranes and roles in innate immunity and wound-healing research — for example, the human cathelicidin LL-37. Most evidence is preclinical; regulatory and safety status differs by compound and is noted per entry.
Category-level context for navigating related peptides and scientific evidence.
Overview
Short, often naturally occurring host-defense peptides studied for interactions with microbial membranes and roles in innate immunity and wound-healing research — for example, the human cathelicidin LL-37. Most evidence is preclinical; regulatory and safety status differs by compound and is noted per entry.
Peptides in this category
KPV
KPV is the tripeptide Lys-Pro-Val (the C-terminal fragment of alpha-MSH) studied in preclinical models for anti-inflammatory activity.
LL-37
LL-37 is the active fragment of the human cathelicidin antimicrobial peptide (hCAP18), an endogenous host-defense peptide. Research describes antimicrobial and immunomodulatory activity studied mainly in vitro and in animal models. Therapeutic applications are investigational and not approved.